Simon X Benito insider trades: Inovio Pharmaceuticals (INO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Simon reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 20, 2022 | INO | ↓ Sell | 2,000 | $2.25 | $5K | Direct | Jul 20, 2022 (0d) |
| Mar 16, 2022 | INO | ↓ Sell | 2,000 | $3.16 | $6K | Direct | Mar 17, 2022 (1d) |
| Jan 19, 2022 | INO | ↓ Sell | 2,000 | $4.27 | $9K | Direct | Jan 21, 2022 (2d) |
| Dec 7, 2021 | DRRX | ↑ Buy | 20,000 | $1.02 | $20K | Direct | Dec 9, 2021 (2d) |
| May 17, 2021 | INO | ↓ Sell | 3,045 | $6.62 | $20K | Direct | May 17, 2021 (0d) |
| Apr 16, 2021 | INO | ↓ Sell | 2,000 | $8.75 | $18K | Direct | Apr 16, 2021 (0d) |
| Mar 16, 2021 | INO | ↓ Sell | 2,000 | $10.41 | $21K | Direct | Mar 16, 2021 (0d) |
| Feb 16, 2021 | INO | ↓ Sell | 2,000 | $14.68 | $29K | Direct | Feb 18, 2021 (2d) |
| Jan 4, 2021 | INO | ↓ Sell | 2,750 | $9.00 | $25K | Direct | Jan 5, 2021 (1d) |
| May 20, 2020 | INO | ↓ Sell | 8,750 | $15.95 | $140K | Direct | May 20, 2020 (0d) |
| Apr 12, 2018 | INO | ↓ Sell | 3,750 | $5.23 | $20K | Direct | Apr 13, 2018 (1d) |
| May 18, 2016 | INO | ↓ Sell | 6,250 | $10.37 | $65K | Direct | May 18, 2016 (0d) |
| Aug 14, 2015 | INO | ↑ Buy | 6,000 | $7.21 | $43K | Direct | Aug 17, 2015 (3d) |
| Mar 10, 2015 | DRRX | ↑ Buy | 40,000 | $1.81 | $72K | Direct | Mar 10, 2015 (0d) |
| Jun 24, 2011 | INO | ↑ Buy | 20,000 | $0.57 | $11K | Direct | Jun 27, 2011 (3d) |
| Nov 14, 2008 | DRRX | ↑ Buy | 5,000 | $3.61 | $18K | Direct | Nov 17, 2008 (3d) |
| Dec 14, 2006 | DRRX | ↑ Buy | 5,000 | $4.60 | $23K | Direct | Dec 18, 2006 (4d) |
| May 19, 2005 | DRRX | ↑ Buy | 5,000 | $3.27 | $16K | Direct | May 20, 2005 (1d) |
| May 11, 2005 | DRRX | ↑ Buy | 5,000 | $3.05 | $15K | Direct | May 12, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Simon X Benito's insider trades
Simon X Benito is a director at Inovio Pharmaceuticals (INO). Since May 11, 2005, Simon has reported 8 open-market purchases worth $220K and 11 sales worth $356K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (41 filings), option exercises (21 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.